Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Biomarker and diagnostic research for neuromyelitis optica spectrum disorder with anti-AQP4 antibodies has been reported in the published literature.
No clinical trials have been registered for neuromyelitis optica spectrum disorder with anti-AQP4 antibodies.
134 publications have been identified in PubMed for neuromyelitis optica spectrum disorder with anti-AQP4 antibodies. Research spans Case Report / Case Series (47%), Epidemiology / Natural History (17%), and Basic Science / Preclinical (14%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 63 | 47% |
Data assembled from 3 of 12 sources · Last updated Sep 21, 2026, 12:29 PM UTC
Program availability and eligibility requirements are set by each foundation. Contact them directly to learn more about your options.
Patient Advocacy Groups (PAGs) provide support, resources, and community for patients and caregivers.
European rare disease database
Genetic and Rare Diseases Info Center
Disease patterns and progression |
23 |
17% |
Laboratory research | 19 | 14% |
Research summaries | 12 | 9% |
Clinical study results | 9 | 7% |
Testing and diagnosis research | 8 | 6% |
Wan F (2026). [PMID: 41593524](https://pubmed.ncbi.nlm.nih.gov/41593524/). *BMC neurology*. [Case Report / Case Series]
Jang Y (2026). [PMID: 41870402](https://pubmed.ncbi.nlm.nih.gov/41870402/). *Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society*. [Case Report / Case Series]
Tsuzaki K (2026). [PMID: 41947891](https://pubmed.ncbi.nlm.nih.gov/41947891/). *Case Rep Neurol Med*. [Case Report / Case Series]
Ren J (2026). [PMID: 41992749](https://pubmed.ncbi.nlm.nih.gov/41992749/). *Brain Behav*. [Basic Science / Preclinical]
Kubo Y (2026). [PMID: 41700230](https://pubmed.ncbi.nlm.nih.gov/41700230/). *Cureus*. [Epidemiology / Natural History]
Chihara N (2026). [PMID: 42032398](https://pubmed.ncbi.nlm.nih.gov/42032398/). *Neurol Ther*. [Epidemiology / Natural History]
Hoshino Y (2026). [PMID: 41740478](https://pubmed.ncbi.nlm.nih.gov/41740478/). *Multiple sclerosis and related disorders*. [Epidemiology / Natural History]
Kinkar JS (2026). [PMID: 41545218](https://pubmed.ncbi.nlm.nih.gov/41545218/). *BMJ case reports*. [Case Report / Case Series]
Jiang Z (2026). [PMID: 41847340](https://pubmed.ncbi.nlm.nih.gov/41847340/). *Frontiers in physiology*. [Case Report / Case Series]
Chen Z (2026). [PMID: 42158871](https://pubmed.ncbi.nlm.nih.gov/42158871/). *Front Immunol*. [Diagnostic / Biomarker]
AI-curated news mentioning neuromyelitis optica spectrum disorder with anti-AQP4 antibodies
Updated Jan 4, 2023
A singer with neuromyelitis optica spectrum disorder (NMOSD) shares her journey to raise awareness and advocate for accurate diagnosis. Her story highlights the importance of patient voices in the rare disease community.